New marker could sharpen cancer targeting

NCT ID NCT05465161

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new device called STING-MARK that helps doctors mark the exact location of a tumor for image-guided treatments. Researchers will use donated organ samples (not live patients) to see if the marker is easy to place, stays in place, and shows up clearly on scans. The goal is to improve accuracy for cancer therapies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHUM

    RECRUITING

    Montreal, Quebec, H2X 0A9, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••